COVID-19, the disease responsible for the devastating pandemic that began at the end of
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …

Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …

Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …

Disordered coagulation, endothelial dysfunction, dehydration and immobility contribute to a
substantially elevated risk of deep venous thrombosis, pulmonary embolism (PE) and …

COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …

Objective To determine the incidence, characteristics, and risk factors of pulmonary
embolism (PE) among patients hospitalized for COVID-19. Patients and Methods We …

Abstract Introduction Coronavirus disease 2019 (COVID-19) has been associated with
cardiovascular complications and coagulation disorders. Previous studies reported …

Recent studies suggest that thrombotic complications are a common phenomenon in the
novel SARS-CoV-2 infection. The main objective of our study is to assess cumulative …

There is some evidence that Covid 19 pneumonia is associated with prothrombotic status
and increased risk of venous thromboembolic events (deep venous thrombosis and …

Hypercoagulability and endotheliopathy reported in patients with coronavirus disease 2019
(COVID-19) combined with strict and prolonged immobilization inherent to deep sedation …